NOVEL EGFR/PI3K DUAL-TARGETING NANOPARTICLES INDUCE IMMUNOGENIC CELL DEATH IN BLADDER CANCER

被引：0
|
作者：
Zhu, Zheng [1 ]
Xue, Xiangdong [2 ]
Zhou, Gang [3 ]
Song, Zewen [4 ]
Li, Guoyin [5 ]
机构：
[1] Harvard Med Sch, West Roxbury, MA USA
[2] Shanghai Jiao Tong Univ, Shanghai, Peoples R China
[3] Fourth Millitary Med Univ, Xian, Peoples R China
[4] Cent South Univ, Changsha, Peoples R China
[5] Zhoukou Normal Univ, Zhoukou, Henan, Peoples R China
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2022年 / 10卷
关键词：
D O I：
10.1136/jitc-2022-SITC2022.1358
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1358
引用
收藏
页码：A1409 / A1409
页数：1
相关论文
共 50 条
  • [31] Targeting Drug-Resistant Prostate Cancer with Dual PI3K/mTOR Inhibition
    Tang, K. D.
    Ling, Ming-Tat
    CURRENT MEDICINAL CHEMISTRY, 2014, 21 (26) : 3048 - 3056
  • [32] A Dual PI3K/HDAC Inhibitor Induces Immunogenic Ferroptosis to Potentiate Cancer Immune Checkpoint Therapy
    Fan, Fushun
    Liu, Pei
    Bao, Rudi
    Chen, Jian
    Zhou, Minhua
    Mo, Zhenxian
    Ma, Yaru
    Liu, Haiqi
    Zhou, Yiping
    Cai, Xiong
    Qian, Changgeng
    Liu, Xinjian
    CANCER RESEARCH, 2021, 81 (24) : 6233 - 6245
  • [33] Inhibiting pancreatic cancer growth by dual targeting of ERK and PI3K signaling.
    Nair, Gauthami G.
    Reindl, Katie
    Quadir, Mohiuddin
    CANCER RESEARCH, 2022, 82 (22) : 104 - 104
  • [34] Brain penetrant HDAC and PI3K/mTOR inhibitors synergize to induce DIPG cell death
    Barnett, Katherine
    Kwon, Hyuk Jean
    Novak, Orlandi
    Eberhart, Charles
    Raabe, Eric
    CANCER RESEARCH, 2022, 82 (12)
  • [35] Targeting PI3K in cancer: any good news?
    Martini, Miriam
    Ciraolo, Elise
    Gulluni, Federico
    Hirsch, Emilio
    FRONTIERS IN ONCOLOGY, 2013, 3
  • [36] Targeting PI3K signaling in cancer: Challenges and advances
    De Santis, Maria Chiara
    Gulluni, Federico
    Campa, Carlo Cosimo
    Martini, Miriam
    Hirsch, Emilio
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2019, 1871 (02): : 361 - 366
  • [37] Targeting PI3K Signaling in Combination Cancer Therapy
    Pons-Tostivint, Elvire
    Thibault, Benoit
    Guillermet-Guibert, Julie
    TRENDS IN CANCER, 2017, 3 (06): : 454 - 469
  • [38] Targeting PI3K/Akt/mTOR signaling in cancer
    Porta, Camillo
    Paglino, Chiara
    Mosca, Alessandra
    FRONTIERS IN ONCOLOGY, 2014, 4
  • [39] A Dual-Targeting Liposome Enhances Triple-Negative Breast Cancer Chemoimmunotherapy through Inducing Immunogenic Cell Death and Inhibiting STAT3 Activation
    Luo, Kaipei
    Yang, Lu
    Yan, Chunmei
    Zhao, Yuxin
    Li, Qiuxia
    Liu, Xing
    Xie, Long
    Sun, Qiang
    Li, Xiaofang
    SMALL, 2023, 19 (40)
  • [40] Targeting the PI3K signaling pathway in cancer therapy
    Bartholomeusz, Chandra
    Gonzalez-Angulo, Ana Maria
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2012, 16 (01) : 121 - 130
12345